Rare structural variants in schizophrenia: one disorder, multiple mutations; one mutation, multiple disorders

Trends in Genetics

Volumn 25, Issue 12, 2009, Pages 528-535

  Sebat, Jonathan ^a   Levy, Deborah L ^b   McCarthy, Shane E ^a  

^a Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

^b MCLEAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID A4 PRECURSOR PROTEIN BINDING A2; BIOLOGICAL MARKER; CONTACTIN ASSOCIATED PROTEIN LIKE 2; DISRUPTED IN SCHIZOPHRENIA 1; NEUREXIN 1; NEURONAL PAS DOMAIN PROTEIN 3; PHOSPHODIESTERASE IVB; UNCLASSIFIED DRUG;

GENE DELETION; GENE DUPLICATION; GENE EXPRESSION PROFILING; GENE MUTATION; GENE TRANSLOCATION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC RISK; GENETIC VARIABILITY; HOMOLOGOUS RECOMBINATION; HUMAN; MULTIFACTORIAL INHERITANCE; MUTATIONAL ANALYSIS; NERVOUS SYSTEM DEVELOPMENT; NEUROBIOLOGY; NONHUMAN; PHENOTYPIC VARIATION; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; DNA COPY NUMBER VARIATIONS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUTATION; SCHIZOPHRENIA;

EID: 70449732249     PISSN: 01689525     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tig.2009.10.004     Document Type: Review

References (116)

1. Cardno A.G., and Gottesman I.I. Twin studies of schizophrenia: from bow-and-arrow concordances to star wars Mx and functional genomics. Am. J. Med. Genet. 97 (2000) 12-17
2. McClellan J.M., et al. Schizophrenia: a common disease caused by multiple rare alleles. Br. J. Psychiatry 190 (2007) 194-199
3. Craddock N., et al. Phenotypic and genetic complexity of psychosis. Invited commentary on . . . Schizophrenia: a common disease caused by multiple rare alleles. Br. J. Psychiatry 190 (2007) 200-203
4. Kendler K.S. "A gene for..": the nature of gene action in psychiatric disorders. Am. J. Psychiatry 162 (2005) 1243-1252
5. Crow T.J. The emperors of the schizophrenia polygene have no clothes. Psychol. Med. 38 (2008) 1681-1685
6. Burmeister M., et al. Psychiatric genetics: progress amid controversy. Nat. Rev. Genet. 9 (2008) 527-540
7. Sanders A.R., et al. No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: implications for psychiatric genetics. Am. J. Psychiatry 165 (2008) 497-506
8. Sullivan P.F., et al. Genomewide association for schizophrenia in the CATIE study: results of stage 1. Mol. Psychiatry 13 (2008) 570-584
9. Kirov G., et al. A genome-wide association study in 574 schizophrenia trios using DNA pooling. Mol. Psychiatry 14 (2009) 796-803
10. Shifman S., et al. Genome-wide association identifies a common variant in the reelin gene that increases the risk of schizophrenia only in women. PLoS Genet. 4 (2008) e28
11. Walsh T., et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 320 (2008) 539-543
12. Consortium TIS. Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 455 (2008) 237-241
13. Stefansson H., et al. Large recurrent microdeletions associated with schizophrenia. Nature 455 (2008) 232-236
14. Rujescu D., et al. Disruption of the neurexin 1 gene is associated with schizophrenia. Hum. Mol. Genet. 18 (2009) 988-996
15. Kirov G., et al. Support for the involvement of large copy number variants in the pathogenesis of schizophrenia. Hum. Mol. Genet. 18 (2009) 1497-1503
16. Purcell S.M., et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460 (2009) 748-752
17. Stefansson H., et al. Common variants conferring risk of schizophrenia. Nature 460 (2009) 744-747
18. Shi J., et al. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 460 (2009) 753-757
19. O'Donovan M.C., et al. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat. Genet. 40 (2008) 1053-1055
20. Feuk L., et al. Structural variation in the human genome. Nat. Rev. Genet. 7 (2006) 85-97
21. Iafrate A.J., et al. Detection of large-scale variation in the human genome. Nat. Genet. 36 (2004) 949-951
22. Sebat J., et al. Large-scale copy number polymorphism in the human genome. Science 305 (2004) 525-528
23. Lupski J.R. Genomic rearrangements and sporadic disease. Nat. Genet. 39 (2007) S43-S47
24. Redon R., et al. Global variation in copy number in the human genome. Nature 444 (2006) 444-454
25. Tuzun E., et al. Fine-scale structural variation of the human genome. Nat. Genet. 37 (2005) 727-732
26. Eichler E.E., et al. Completing the map of human genetic variation. Nature 447 (2007) 161-165
27. Ji W., et al. Rare independent mutations in renal salt handling genes contribute to blood pressure variation. Nat. Genet. 40 (2008) 592-599
28. Ahituv N., et al. Medical sequencing at the extremes of human body mass. Am. J. Hum. Genet. 80 (2007) 779-791
29. Azzopardi D., et al. Multiple rare nonsynonymous variants in the adenomatous polyposis coli gene predispose to colorectal adenomas. Cancer Res. 68 (2008) 358-363
30. Bodmer W., and Bonilla C. Common and rare variants in multifactorial susceptibility to common diseases. Nat. Genet. 40 (2008) 695-701
31. Cohen J.C., et al. Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science 305 (2004) 869-872
32. Cohen J.C., et al. Multiple rare variants in NPC1L1 associated with reduced sterol absorption and plasma low-density lipoprotein levels. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 1810-1815
33. Fearnhead N.S., et al. Multiple rare variants in different genes account for multifactorial inherited susceptibility to colorectal adenomas. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 15992-15997
34. Fearnhead N.S., et al. Rare variant hypothesis for multifactorial inheritance: susceptibility to colorectal adenomas as a model. Cell Cycle 4 (2005) 521-525
35. Li B., and Leal S.M. Discovery of Rare Variants via Sequencing: Implications for Association Studies. PLoS Genet. 5 (2008) e1000481
36. Xu B., et al. Strong association of de novo copy number mutations with sporadic schizophrenia. Nat. Genet. 40 (2008) 880-885
37. Karayiorgou M., et al. Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 7612-7616
38. Millar J.K., et al. Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum. Mol. Genet. 9 (2000) 1415-1423
39. Millar J.K., et al. DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling. Science 310 (2005) 1187-1191
40. Pickard B.S., et al. Disruption of a brain transcription factor, NPAS3, is associated with schizophrenia and learning disability. Am. J. Med. Genet. B 136 (2005) 26-32
41. Chubb J.E., et al. The DISC locus in psychiatric illness. Mol. Psychiatry 13 (2008) 36-64
42. Ousley O., et al. A review of neurocognitive and behavioral profiles associated with 22q11 deletion syndrome: implications for clinical evaluation and treatment. Curr. Psychiatry Rep. 9 (2007) 148-158
43. Albertson D.G., and Pinkel D. Genomic microarrays in human genetic disease and cancer. Hum. Mol. Genet. 12 (2003) R145-R152
44. Lucito R., et al. Representational oligonucleotide microarray analysis: a high-resolution method to detect genome copy number variation. Genome Res. 13 (2003) 2291-2305
45. Pollack J.R., et al. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 12963-12968
46. Shaw-Smith C., et al. Microarray based comparative genomic hybridisation (array-CGH) detects submicroscopic chromosomal deletions and duplications in patients with learning disability/mental retardation and dysmorphic features. J. Med. Genet. 41 (2004) 241-248
47. Zhang D., et al. Singleton deletions throughout the genome increase risk of bipolar disorder. Mol. Psychiatry 14 (2009) 376-380
48. Shi Y.Y., et al. A study of rare structural variants in schizophrenia patients and normal controls from Chinese Han population. Mol. Psychiatry 13 (2008) 911-913
49. Need A.C., et al. A genome-wide investigation of SNPs and CNVs in schizophrenia. PLoS Genet. 5 (2009) e1000373
50. Sebat J., et al. Strong association of de novo copy number mutations with autism. Science 316 (2007) 445-449
51. Marshall C.R., et al. Structural variation of chromosomes in autism spectrum disorder. Am. J. Hum. Genet. 82 (2008) 477-488
52. Xu B., et al. Elucidating the genetic architecture of familial schizophrenia using rare copy number variant and linkage scans. Proc. Natl. Acad. Sci. U. S. A. 106 (2009) 16746-16751
53. McCarthy, S. et al. Microduplications of 16p11.2 are associated with schizophrenia. Nat Genet. 2009 Oct 25. [Epub ahead of print]
54. Ingason, A. et al. Copy number variations of chromosome 16p13.1 region associated with schizophrenia. Mol. Psychiatry 2009 Sep 29. [Epub ahead of print]
55. Kirov G., et al. Comparative genome hybridization suggests a role for NRXN1 and APBA2 in schizophrenia. Hum. Mol. Genet. 17 (2008) 458-465
56. Friedman J.I., et al. CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy. Mol. Psychiatry 13 (2008) 261-266
57. Murphy K.C., et al. High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch. Gen. Psychiatry 56 (1999) 940-945
58. Bassett A.S., et al. 22q11 deletion syndrome in adults with schizophrenia. Am. J. Med. Genet. 81 (1998) 328-337
59. Gothelf D., et al. Velocardiofacial manifestations and microdeletions in schizophrenic inpatients. Am. J. Med. Genet. 72 (1997) 455-461
60. Brunetti-Pierri N., et al. Recurrent reciprocal 1q21.1 deletions and duplications associated with microcephaly or macrocephaly and developmental and behavioral abnormalities. Nat. Genet. 40 (2008) 1466-1471
61. Sharp A.J., et al. A recurrent 15q13.3 microdeletion syndrome associated with mental retardation and seizures. Nat. Genet. 40 (2008) 322-328
62. Weiss L.A., et al. Association between microdeletion and microduplication at 16p11.2 and autism. N. Engl. J. Med. 358 (2008) 667-675
63. Kumar R.A., et al. Recurrent 16p11.2 microdeletions in autism. Hum. Mol. Genet. 17 (2008) 628-638
64. Hannes F.D., et al. Recurrent reciprocal deletions and duplications of 16p13.11: the deletion is a risk factor for MR/MCA while the duplication may be a rare benign variant. J. Med. Genet. 46 (2009) 223-232
65. Szatmari P., et al. Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat. Genet. 39 (2007) 319-328
66. Kim H.G., et al. Disruption of neurexin 1 associated with autism spectrum disorder. Am. J. Hum. Genet. 82 (2008) 199-207
67. Sebat J. Major changes in our DNA lead to major changes in our thinking. Nat. Genet. 39 (2007) S3-S5
68. Fisher R.A. The correlation between relatives on the supposition of Mendelian inheritance. Phil. Trans. Roy. Soc. Edinb. 52 (1918) 399-433
69. Gothelf D., et al. Genetic, developmental, and physical factors associated with attention deficit hyperactivity disorder in patients with velocardiofacial syndrome. Am. J. Med. Genet. B 126 (2004) 116-121
70. Mefford H.C., et al. Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes. N. Engl. J. Med. 359 (2008) 1685-1699
71. Helbig I., et al. 15q13.3 microdeletions increase risk of idiopathic generalized epilepsy. Nat. Genet. 41 (2009) 160-162
72. Dibbens L.M., et al. Familial and sporadic 15q13.3 microdeletions in idiopathic generalized epilepsy: precedent for disorders with complex inheritance. Hum. Mol. Genet. 18 (2009) 3626-3631
73. Sharp A.J., et al. Discovery of previously unidentified genomic disorders from the duplication architecture of the human genome. Nat. Genet. 38 (2006) 1038-1042
74. Guilmatre A., et al. Recurrent rearrangements in synaptic and neurodevelopmental genes and shared biologic pathways in schizophrenia, autism, and mental retardation. Arch. Gen. Psychiatry 66 (2009) 947-956
75. Mardis E.R. The impact of next-generation sequencing technology on genetics. Trends Genet. 24 (2008) 133-141
76. Bentley D.R., et al. Accurate whole human genome sequencing using reversible terminator chemistry. Nature 456 (2008) 53-59
77. Wang J., et al. The diploid genome sequence of an Asian individual. Nature 456 (2008) 60-65
78. Wheeler D.A., et al. The complete genome of an individual by massively parallel DNA sequencing. Nature 452 (2008) 872-876
79. Korbel J.O., et al. Paired-end mapping reveals extensive structural variation in the human genome. Science 318 (2007) 420-426
80. Yoon S., et al. Sensitive and accurate detection of copy number variants using read depth of coverage. Genome Res. 19 (2009) 1586-1592
81. Alkan C., et al. Personalized copy number and segmental duplication maps using next-generation sequencing. Nat. Genet. 41 (2009) 1061-1067
82. Chiang D.Y., et al. High-resolution mapping of copy-number alterations with massively parallel sequencing. Nat. Methods 6 (2009) 99-103
83. Hodges E., et al. Genome-wide in situ exon capture for selective resequencing. Nat. Genet. 39 (2007) 1522-1527
84. Albert T.J., et al. Direct selection of human genomic loci by microarray hybridization. Nat. Methods 4 (2007) 903-905
85. Stark A., et al. Animal MicroRNAs confer robustness to gene expression and have a significant impact on 3'UTR evolution. Cell 123 (2005) 1133-1146
86. Walz K., et al. Behavioral characterization of mouse models for Smith-Magenis syndrome and dup(17)(p11.2p11.2). Hum. Mol. Genet. 13 (2004) 367-378
87. Lupski J.R., et al. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 66 (1991) 219-232
88. Nakatani J., et al. Abnormal behavior in a chromosome-engineered mouse model for human 15q11-13 duplication seen in autism. Cell 137 (2009) 1235-1246
89. Bi W., et al. Inactivation of Rai1 in mice recapitulates phenotypes observed in chromosome engineered mouse models for Smith-Magenis syndrome. Hum. Mol. Genet. 14 (2005) 983-995
90. Missler M., et al. Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis. Nature 423 (2003) 939-948
91. Shahbazian M., et al. Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron 35 (2002) 243-254
92. The Dutch-Belgian Fragile X Consortium (1994) Fmr1 knockout mice: a model to study fragile X mental retardation. Cell 78, 23-33
93. Passage E., et al. Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease. Nat. Med 10 (2004) 396-401
94. Kaya F., et al. Ascorbic acid inhibits PMP22 expression by reducing cAMP levels. Neuromuscul. Disord. 17 (2007) 248-253
95. Yan Q.J., et al. Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP. Neuropharmacology 49 (2005) 1053-1066
96. Dolen G., et al. Correction of fragile X syndrome in mice. Neuron 56 (2007) 955-962
97. de Vrij F.M., et al. Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice. Neurobiol. Dis. 31 (2008) 127-132
98. Nishimura Y., et al. Genome-wide expression profiling of lymphoblastoid cell lines distinguishes different forms of autism and reveals shared pathways. Hum. Mol. Genet. 16 (2007) 1682-1698
99. Yu J., et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318 (2007) 1917-1920
100. Takahashi K., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131 (2007) 861-872
101. Hotta A., et al. Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency. Nat. Methods 6 (2009) 370-376
102. Kremen W.S., et al. Is the Wisconsin Card Sorting Test a useful neurocognitive endophenotype? Am. J. Med. Genet. B 144 (2007) 403-406
103. Jablensky A. Subtyping schizophrenia: implications for genetic research. Mol. Psychiatry 11 (2006) 815-836
104. Waddington J.L., et al. Magnetic resonance imaging and spectroscopy in schizophrenia. Br. J. Psychiatry Suppl. (1990) 56-65
105. Nikolaus S., et al. In vivo imaging of synaptic function in the central nervous system. II. Mental and affective disorders. Behav. Brain Res. 204 (2009) 32-66
106. Koolen D.A., et al. A new chromosome 17q21.31 microdeletion syndrome associated with a common inversion polymorphism. Nat. Genet. 38 (2006) 999-1001
107. Shaw-Smith C., et al. Microdeletion encompassing MAPT at chromosome 17q21.3 is associated with developmental delay and learning disability. Nat. Genet. 38 (2006) 1032-1037
108. Gottesman I.I., and Gould T.D. The endophenotype concept in psychiatry: etymology and strategic intentions. Am. J. Psychiatry 160 (2003) 636-645
109. Yan J., et al. Neurexin 1alpha structural variants associated with autism. Neurosci. Lett. 438 (2008) 368-370
110. Doornbos M., et al. Nine patients with a microdeletion 15q11.2 between breakpoints 1 and 2 of the Prader-Willi critical region, possibly associated with behavioural disturbances. Eur. J. Med. Genet. 52 (2009) 108-115
111. Chance P.F., et al. DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell 72 (1993) 143-151
112. Mefford H.C., et al. A method for rapid, targeted CNV genotyping identifies rare variants associated with neurocognitive disease. Genome Res 19 (2009) 1579-1585
113. Elia, J. et al. Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes. Mol. Psychiatry 2009 Jun 23. [Epub ahead of print]
114. Bakkaloglu B., et al. Molecular cytogenetic analysis and resequencing of contactin associated protein-like 2 in autism spectrum disorders. Am. J. Hum. Genet. 82 (2008) 165-173
115. Arking D.E., et al. A common genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk of autism. Am. J. Hum. Genet. 82 (2008) 160-164
116. Alarcon M., et al. Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene. Am. J. Hum. Genet. 82 (2008) 150-159